Vaxart share price logo

Vaxart

OTC: VXRT

$0.42

-0.02

(-4.76%)

Live

as on

Vaxart Stock Performance

as on October 24, 2026 at 6:22 am IST

  • Day's Low

    Day's High

    $0.41
    $0.45
    downward going graph

    2.38%

    Downside

    7.14%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.31
    $0.84
    downward going graph

    27.38%

    Downside

    101.17%

    Upside

    downward going graph

Vaxart share price movements today

Previous Close
$0.44
Open
$0.45
Volume
1.7M
Market Cap
$119.0M
Day's Low - High
$0.41 - $0.45
52 Week Low - High
$0.31 - $0.84

Vaxart Historical Returns

1 Month Return
-8.09 %
3 Month Return
-11.71 %
1 Year Return
+ 21.49 %
3 Year Return
-33.18 %
5 Year Return
-93.46 %

Vaxart Stock Fundamentals & Key Indicators

Check Vaxart market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$119.0M

EPS (TTM)

0.15

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

3.13

Industry PE ratio

-2.60

PEG Ratio

0.00

EBITDA

47.2M

Revenue (TTM)

243.1M

Profit Margin

100.00%

Return On Equity TTM

53.04%

Vaxart vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Vaxart with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$119.0M-93.46%3.13100.00%0.00%
Neutral$98.1B-37.95%-30.80-12.57%0.00%
StrongBuy$44.0BNA27.4787.82%0.00%
StrongBuy$132.9B191.61%30.2886.04%0.00%
Buy$83.1B43.11%19.2484.86%0.46%

Stock Returns calculator for Vaxart Stock including INR - Dollar returns

The Vaxart stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Vaxart investment value today

Current value as on today

₹1,25,141

Returns

₹25,141

(+25.14%)

Returns from Vaxart Stock

₹15,702 (+15.7%)

Dollar Impact

₹9,439 (+9.44%)

Analyst Recommendation on Vaxart Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Vaxart. Average target price of $3.33

Vaxart Share Price Target

Get share price movements and forecasts by analysts on Vaxart.

What analysts predicted

87.39%UPSIDE

Target Price

$3.33

Current Price

$0.42

Analyzed by

9 Analysts

Target

$3.33

Vaxart target price $3.33, a slight upside of 87.39% compared to current price of $0.42. According to 9 analysts rating.

Indian Investors' Interest in Vaxart Stock

Search interest for Vaxart Stock has decreased by -2% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-2% versus previous 30 day period

Vaxart Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
2
6
4
15
20
39
72
104
39
27
Gross Profit
2
6
4
15
20
39
72
104
39
27
Operating Income
-24
-16
-14
-11
-14
-14
-7
55
5
-13
EBITDA
-21
-13
-11
-8
-12
-12
-5
57
6
-12
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
2
2
2
2
2
2
2
2
1
0
Income Before Tax
-24
-16
-14
-11
-15
-14
-8
55
5
-13
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-24
-16
-14
-11
-15
-14
-8
55
5
-13
Net Profit Margin
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%

Vaxart Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
5
4
9
4
0
0
7
28
237
Gross Profit
-6
-13
9
-15
-47
0
2
28
237
Operating Income
-9
-21
-15
-30
-72
-114
-83
-66
18
EBITDA
-8
-12
-12
-27
-64
-100
-72
-54
28
Interest Expense
-
2
2
1
1
1
1
2
2
Depreciation
0
3
3
2
4
5
8
8
8
Income Before Tax
-9
-17
-18
-31
-70
-107
-82
-66
16
Income Tax Expense
-
0
0
0
0
0
0
0
0
Net Income
-12
-18
-18
-32
-70
-107
-82
-66
16
Net Profit Margin
-111.59%
-315.36%
100.00%
-390.93%
-5365.13%
100.00%
39.02%
100.00%
100.00%

Vaxart Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-24
-16
-14
-11
-15
-14
-8
55
5
-13
Operating Cash Flow
-21
-12
-4
-7
-9
-15
2
30
-2
2
Investing Cash Flow
-5
-9
-17
10
13
7
-5
1
0
-2
Financing Cash Flow
18
38
0
0
0
0
0
4
0
0
Change in Cash
-8
16
-21
3
3
-8
-3
36
-3
0

Vaxart Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-9
-18
-18
-32
-70
-107
-82
-66
16
Operating Cash Flow
-10
-14
-13
-23
-59
-94
-70
-44
7
Investing Cash Flow
3
26
0
-1
-49
-20
43
-21
16
Financing Cash Flow
0
-1
15
138
125
17
15
56
4
Change in Cash
-6
9
2
113
16
-97
-11
-9
28

Global Institutional Holdings in Vaxart

Check out the Institutions with significant holdings in Vaxart.

Funds
Holdings
Victory Portfolios III
0.01%

Vaxart News & Key Events

  • img

    Today's Timeline - 19 October

    Mon, 05:30 PM

    -

    Vaxart appoints Raquel C. Bono to Board of Directors, enhancing governance and strategic efforts.

Insights on Vaxart

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 671.9% return, outperforming this stock by 650.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 157.7% return, outperforming this stock by 190.9%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, VXRT stock has moved down by -40.4%

About Vaxart

Vaxart, Inc. operates as a biotechnology firm currently in the clinical development phase, concentrating its efforts on identifying and advancing novel oral recombinant protein vaccines. The company leverages its unique proprietary platform for delivering these oral vaccine solutions. Its diverse pipeline showcases several promising candidates: An oral tablet vaccine targeting norovirus, which is presently undergoing Phase Ib clinical assessment for both GI.1 and GII.4 strains. A seasonal influenza vaccine, now in Phase II clinical studies, designed to address H1 influenza infections. A vaccine candidate against respiratory syncytial virus (RSV). A coronavirus vaccine, also advancing through Phase II clinical trials for SARS-CoV-2. Beyond infectious diseases, Vaxart is also engaged in formulating therapeutic vaccines aimed at treating cervical cancer and dysplasia associated with human papillomavirus. The company's main operations are situated in South San Francisco, California.
OrganisationVaxart
Headquarters310 Utah Avenue, South San Francisco, CA, 94080, US
IndustryBiotechnology
CEOSteven Lo

Key Management of Vaxart

Name

Title

Dr. James F. Cummings M.D.

Chief Medical Officer

Mr. Jeroen Grasman M.B.A.

CFO, Principal Accounting Officer & Principal Financial Officer

Mr. Todd Lopeman

Chief Technology Officer

Mr. Edward B. Berg

Senior VP & General Counsel

Ms. Laurie Hastings

Senior Vice President of Human Resources

Dr. Rajesh Kapoor Ph.D.

Senior Vice President of Quality

Mr. Steven Lo

President, CEO & Director

Dr. Sean N. Tucker Ph.D.

Senior VP & Chief Scientific Officer

FAQs

What is Vaxart share price today?

Vaxart share price today is $0.42 as on . Vaxart share today touched a day high of $0.45 and a low of $0.41.

What is the 52 week high and 52 week low for Vaxart share?

Vaxart share touched a 52 week high of $0.84 on and a 52 week low of $0.31 on . Vaxart stock price today i.e. is trending at $0.42,which is 50.29% down from its 52 week high and 37.70% up from its 52 week low.

What is Vaxart's market capitalisation today?

Vaxart market capitalisation is $0.00T as on .

How to invest in Vaxart Stock (VXRT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Vaxart on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Vaxart Stock (VXRT) from India?

Indian investors can start investing in Vaxart (VXRT) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Vaxart stock (as per the Rupee-Dollar exchange rate as on ). Based on Vaxart share’s latest price of $0.42 as on October 24, 2026 at 12:52 am IST, you will get 23.8095 shares of Vaxart. Learn more about fractional shares .

What are the returns that Vaxart has given to Indian investors in the last 5 years?

Vaxart stock has given -93.46% share price returns and 26.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?